|
Market Closed -
Australian S.E.
18:59:13 2026-10-14 EDT
|
5-day change | 1st Jan Change | ||
| 0.002000 AUD | 0.00% |
|
0.00% | -96.00% |
| 10-02 | Nexalis Therapeutics Appoints Non-Executive Chairman | MT |
| 08-31 | Spenda Limited Reports Earnings Results for the Full Year Ended June 30, 2026 | CI |
Company Valuation: Spenda Limited
Data adjusted to current consolidation scope
| Fiscal Period: June | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 134.8 | 28.63 | 29.2 | 34.6 | 32.31 | 2.303 |
| Change | - | -78.75% | 1.98% | 18.47% | -6.62% | -92.87% |
| Enterprise Value (EV) 1 | 113.4 | 29.29 | 33.11 | 38.64 | 33.38 | 3.944 |
| Change | - | -74.17% | 13.04% | 16.72% | -13.63% | -88.18% |
| P/E | -7.54x | -0.56x | -2.35x | -2.39x | -1.31x | -0.03x |
| PBR | 1.78x | 0.66x | 0.76x | 1x | 2.09x | -0.62x |
| PEG | - | -0x | 0x | 1.41x | -0x | 0x |
| Capitalization / Revenue | 154x | 12.7x | 9.38x | 6.44x | 2.91x | 0.26x |
| EV / Revenue | 129x | 13x | 10.6x | 7.19x | 3.01x | 0.45x |
| EV / EBITDA | -16.1x | -1.96x | -3.21x | -3.73x | -2.86x | -0.46x |
| EV / EBIT | -16.1x | -1.95x | -3.05x | -3.62x | -2.83x | -0.45x |
| EV / FCF | 37.6x | -1.33x | -75.4x | -17.7x | 5.95x | -1.46x |
| FCF Yield | 2.66% | -75.2% | -1.33% | -5.65% | 16.8% | -68.6% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -0.13 | -0.324 | -0.068 | -0.0668 | -0.1069 | -0.0866 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 0.8778 | 2.246 | 3.112 | 5.375 | 11.08 | 8.78 |
| EBITDA 1 | -7.033 | -14.96 | -10.31 | -10.35 | -11.67 | -8.593 |
| EBIT 1 | -7.045 | -15.05 | -10.85 | -10.67 | -11.81 | -8.685 |
| Net income 1 | -11.41 | -50.24 | -11 | -13.21 | -24.31 | -24.02 |
| Net Debt 1 | -21.36 | 0.6543 | 3.907 | 4.048 | 1.071 | 1.641 |
| Reference price 2 | 0.980000 | 0.180000 | 0.160000 | 0.160000 | 0.140000 | 0.003000 |
| Nbr of stocks (in thousands) | 137,509 | 159,083 | 182,509 | 216,223 | 230,761 | 767,679 |
| Announcement Date | 8/31/21 | 8/31/22 | 8/31/23 | 8/28/24 | 9/30/25 | 8/31/26 |
1AUD in Million2AUD
Estimates
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 1.68M | |
| 26.83x | 9.91x | 16.18x | 0.73% | 3,928B | |
| 119.93x | 52.98x | 86.28x | -.--% | 447B | |
| 19.3x | 5.59x | 9.74x | 1.56% | 389B | |
| 216.99x | 19.31x | 56.52x | -.--% | 280B | |
| 28.38x | 5.66x | 17.83x | 1.34% | 259B | |
| 2273.9x | 37.98x | 124.23x | -.--% | 233B | |
| 90.05x | 8.93x | 23.9x | -.--% | 147B | |
| 54.84x | 14.71x | 38.75x | -.--% | 124B | |
| 13.44x | 3.57x | 7.47x | -.--% | 95.43B | |
| Average | 315.96x | 17.63x | 42.32x | 0.4% | 590.23B | |
| Weighted average by Cap. | 133.24x | 14.23x | 27.85x | 0.65% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- SPX Stock
- Valuation Spenda Limited
Select your edition
All financial news and data tailored to specific country editions
